Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

By Schuster Michael  

Supportive Care in Cancer, Vol. 16, Iss. 5, 2008-05 ,pp. : 477-483

Springer Publishing Company

Access to resources Recommend Favorite

Quality of Life in Ovarian Cancer Patients Receiving Chemotherapy

By Lakusta C.M.   Atkinson M.J.   Robinson J.W.   Nation J.   Taenzer P.A.   Campo M.G.  

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 490-495

Elsevier

Access to resources Recommend Favorite

Pulmonary toxicity in patients receiving docetaxel chemotherapy

By Yumuk Perran  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1381-1388

Humana Press, Inc

Access to resources Recommend Favorite

A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients

By Pierga Jean-Yves   Delaloge Suzette   Espié Marc   Brain Etienne   Sigal-Zafrani Brigitte   Mathieu Marie-Christine   Bertheau Philippe   Guinebretière Jean   Spielmann Marc   Savignoni Alexia   Marty Michel  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 429-437

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab in Combination with Chemotherapy

By Burstein Harold J.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 69-72

Springer Publishing Company

Access to resources Recommend Favorite